Civic Intelligence

Slay Sarcoma Research Initiative

EIN 81-0699146 • 501(c)3 • Yardley, PA

Profile

The exempt purpose is to raise funds and awareness to support scientific research in the public interest. Slay sarcoma research initiative inc. Grants will serve the wider public by seeking a cure for leiomyosarcoma.

609 Lauren CircleYardley, PA 19067

www.slaysarcoma.com

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on the latest valid filing.

Source year 2024

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on the latest valid filing.

Source year 2024

Net Margin

56th percentile

5.0%

Higher net margin than 56% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Top Officer Pay

81st percentile

$0

Higher top officer pay than 81% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2024

Asset Growth

90th percentile

81%

Faster asset growth than 90% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Revenue Growth

33rd percentile

-21%

Faster revenue growth than 33% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / AssetsScore unavailable

Assets

Up

$4,309

Up $1,926 (+81%) from 2023

Liabilities

-

No earlier filing loaded for comparison.

Net Assets

Up

$4,309

Up $1,926 (+81%) from 2023

Operations
Liabilities / RevenueScore unavailableNet Margin56th percentile

Revenue

Down

$38,664

Down $10,184 (-21%) from 2023

Expenses

Down

$36,738

Down $15,261 (-29%) from 2023

Net Income

Up

$1,926

Up $5,077 (+161%) from 2023

Trend Graphs

Balance Sheet Trend

Asset Growth90th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$100K$50K$0Assets 2015: $1Liabilities 2015: $02015Assets 2016: $47,401Net Assets 2016: $47,4012016Assets 2017: $98,569Net Assets 2017: $98,5692017Assets 2018: $39,514Liabilities 2018: $8Net Assets 2018: $39,5062018Assets 2019: $46,397Net Assets 2019: $46,3972019Assets 2020: $9,033Net Assets 2020: $9,0332020Assets 2021: $5,091Net Assets 2021: $5,0912021Assets 2022: $5,539Net Assets 2022: $5,5392022Assets 2023: $2,383Net Assets 2023: $2,3832023Assets 2024: $4,309Net Assets 2024: $4,3092024

Highlighted filing

2024

Assets$4,309
Liabilities-
Net Assets$4,309
Open 2024 Filing

Operations Trend

Revenue Growth33rd percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$150K$100K$50K$0-$50K-$100KRevenue 2015: $0Expenses 2015: $0Net Income 2015: $02015Revenue 2016: $48,584Expenses 2016: $1,183Net Income 2016: $47,4012016Revenue 2017: $98,418Expenses 2017: $47,250Net Income 2017: $51,1682017Revenue 2018: $41,771Expenses 2018: $100,834Net Income 2018: -$59,0632018Revenue 2019: $49,150Expenses 2019: $42,259Net Income 2019: $6,8912019Revenue 2020: $5,600Expenses 2020: $42,964Net Income 2020: -$37,3642020Revenue 2021: $32,895Expenses 2021: $36,837Net Income 2021: -$3,9422021Revenue 2022: $45,031Expenses 2022: $44,583Net Income 2022: $4482022Revenue 2023: $48,848Expenses 2023: $51,999Net Income 2023: -$3,1512023Revenue 2024: $38,664Expenses 2024: $36,738Net Income 2024: $1,9262024

Highlighted filing

2024

Revenue$38,664
Expenses$36,738
Net Income$1,926
Open 2024 Filing

Filings

Most recent year

2024 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$4,309
Liabilities
-
Net assets
$4,309
Revenue
$38,664
Expenses
$36,738
Net income
$1,926
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$0.04$0.04$0.39$0.37$0.02
2023Detailed filing. Detailed filing data is available for this year.$0.02$0.02$0.49$0.52$0.03
2022Detailed filing. Detailed filing data is available for this year.$0.06$0.06$0.45$0.45$0.00
2021Detailed filing. Detailed filing data is available for this year.$0.05$0.05$0.33$0.37$0.04
2020Detailed filing. Detailed filing data is available for this year.$0.09$0.09$0.06$0.43$0.37
2019Detailed filing. Detailed filing data is available for this year.$0.46$0.46$0.49$0.42$0.07
2018Detailed filing. Detailed filing data is available for this year.$0.40$0.00$0.40$0.42$1.01$0.59
2017Detailed filing. Detailed filing data is available for this year.$0.99$0.99$0.98$0.47$0.51
2016Detailed filing. Detailed filing data is available for this year.$0.47$0.47$0.49$0.01$0.47
2015Summary only. Only limited summary data is available for this year.$0.00$0.00$0.00$0.00$0.00
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
Apr 29, 2025
Return Version
2024v5.0
Gross Receipts
$47,578
Mission and Program Overview

Mission

The exempt purpose is to raise funds and awareness to support scientific research in the public interest. Slay sarcoma research initiative inc. Grants will serve the wider public by seeking a cure for leiomyosarcoma.

Program Services

DescriptionGrantsExpenses
TO PROVIDE RESEARCH GRANTS WITH THE TARGETED PURPOSE OF RESEARCHING A CURE FOR LEIOMYOSARCOMA. ONE RESEARCH GRANT WAS DISTRIBUTED IN 2023.$35,000$35,000
Compensation and Service Providers
Top Officer Pay81st percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
JOANN TRAINERCEO & Direct-$0--
AMBER TRAINERSecretary &-$0--
ALISON PERATEVP & Directo-$0--
ANDREA KEALYPresident &-$0--
SARAH TRAINERTreasurer &-$0--
Fundraising, Events, and Gaming

Fundraising Events

EventGross ReceiptsGross RevenueDirect ExpensesNet Income
5k Race$28,647$19,525$7,664$11,861
Total Events$28,647$19,525$8,914$10,611
Filing and Contact Details

Filer

Filer Name
Slay Sarcoma Research Initiative
EIN
81-0699146
Phone
2159329040
Address
609 LAUREN CIRCLE, YARDLEY, PA 19067

Signing Officer

Name
Sarah Trainer
Title
Treasurer & Director
Phone
2159329040
Signed
2025-04-29
Discuss with paid preparer
Yes

Preparer

Firm
Five Points Financial LLC
Address
2667 NOTTINGHAM WAY, HAMILTON, NJ 08619
Preparer
David a Lauer CPA
Phone
6095863600
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 10

“Name: abramson cancer center address: university of penn philadelphia, pa 19104 cash contribution: 35,000”

Form 990-ez, Part I, Line 16

“5k race insurance 165 expenses web advertising 288 software & subscriptions 267 pa filing fee 100 total 820”

Form 990-ez, Part III

“The exempt purpose is to raise funds and awareness to support scientific research in the public interest. Slay sarcoma research initiative inc. Grants will serve the wider public by seeking a cure for leiomyosarcoma.”

Raw XML Appendix153 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0SARAH TRAINER
IRS990EZ/BooksInCareOfDetail/PhoneNum02159329040
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt0609 LAUREN CIRCLE
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0YARDLEY
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0PA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd019067
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt02383
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt04309
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt028048
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt01926
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt0610
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt02383
IRS990EZ/Form990TotalAssetsGrp/EOYAmt04309
IRS990EZ/FundraisingGrossIncomeAmt019525
IRS990EZ/GrantsAndSimilarAmountsPaidAmt035000
IRS990EZ/GrossReceiptsAmt047578
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InvestmentIncomeAmt05
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt02383
IRS990EZ/NetAssetsOrFundBalancesEOYAmt04309
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt02383
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt04309
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt02.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt11.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt21.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt31.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt41.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0JOANN TRAINER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1AMBER TRAINER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2ALISON PERATE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3ANDREA KEALY
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4SARAH TRAINER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0CEO & DIRECT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1SECRETARY &
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2VP & DIRECTO
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3PRESIDENT &
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4TREASURER &
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt0820
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0THE EXEMPT PURPOSE IS TO RAISE FUNDS AND AWARENESS TO SUPPORT SCIENTIFIC RESEARCH IN THE PUBLIC INTEREST. SLAY SARCOMA RESEARCH INITIATIVE INC. GRANTS WILL SERVE THE WIDER PUBLIC BY SEEKING A CURE FOR LEIOMYOSARCOMA.
IRS990EZ/PrintingPublicationsPostageAmt0308
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0TO PROVIDE RESEARCH GRANTS WITH THE TARGETED PURPOSE OF RESEARCHING A CURE FOR LEIOMYOSARCOMA. ONE RESEARCH GRANT WAS DISTRIBUTED IN 2023.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt035000
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt035000
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SpecialEventsDirectExpensesAmt08914
IRS990EZ/SpecialEventsNetIncomeLossAmt010611
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0PA
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt036738
IRS990EZ/TotalProgramServiceExpensesAmt035000
IRS990EZ/TotalRevenueAmt038664
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.SLAYSARCOMA.COM
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt028048
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt038235
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt030370
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt027291
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt05292
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt0129236
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt075939
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct01.00000
IRS990ScheduleA/PublicSupportPY170Pct01.00000
IRS990ScheduleA/PublicSupportTotal170Amt0129236
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt028048
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt038235
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt030370
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt027291
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt05292
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt0129236
IRS990ScheduleA/TotalSupportAmt0129236
IRS990ScheduleG/FundraisingEventInformationGrp/CharitableContributionsTotAmt09122
IRS990ScheduleG/FundraisingEventInformationGrp/CharitableContriEvent1Amt09122
IRS990ScheduleG/FundraisingEventInformationGrp/DirectExpenseSummaryEventsAmt08914
IRS990ScheduleG/FundraisingEventInformationGrp/EntertainmentEvent1Amt0750
IRS990ScheduleG/FundraisingEventInformationGrp/EntertainmentTotalEventsAmt0750
IRS990ScheduleG/FundraisingEventInformationGrp/Event1Nm05K RACE
IRS990ScheduleG/FundraisingEventInformationGrp/GrossReceiptsEvent1Amt028647
IRS990ScheduleG/FundraisingEventInformationGrp/GrossReceiptsTotalAmt028647
IRS990ScheduleG/FundraisingEventInformationGrp/GrossRevenueEvent1Amt019525
IRS990ScheduleG/FundraisingEventInformationGrp/GrossRevenueTotalEventsAmt019525
IRS990ScheduleG/FundraisingEventInformationGrp/NetIncomeSummaryAmt010611
IRS990ScheduleG/FundraisingEventInformationGrp/OthDirectExpnssTotalEventsAmt07664
IRS990ScheduleG/FundraisingEventInformationGrp/OtherDirectExpensesEvent1Amt07664
IRS990ScheduleG/FundraisingEventInformationGrp/RentFacilityCostsEvent1Amt0500
IRS990ScheduleG/FundraisingEventInformationGrp/RentFcltyCostsTotalEventsAmt0500
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0NAME: ABRAMSON CANCER CENTER ADDRESS: UNIVERSITY OF PENN PHILADELPHIA, PA 19104 CASH CONTRIBUTION: 35,000
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt15K RACE INSURANCE 165 EXPENSES WEB ADVERTISING 288 SOFTWARE & SUBSCRIPTIONS 267 PA FILING FEE 100 TOTAL 820
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2THE EXEMPT PURPOSE IS TO RAISE FUNDS AND AWARENESS TO SUPPORT SCIENTIFIC RESEARCH IN THE PUBLIC INTEREST. SLAY SARCOMA RESEARCH INITIATIVE INC. GRANTS WILL SERVE THE WIDER PUBLIC BY SEEKING A CURE FOR LEIOMYOSARCOMA.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 10
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART I, LINE 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART III
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0SARAH TRAINER
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0TREASURER & DIRECTOR
ReturnHeader/BusinessOfficerGrp/PhoneNum02159329040
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-04-29
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0SLAY SARCOMA RESEARCH INITIATIVE
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0INC
ReturnHeader/Filer/BusinessNameControlTxt0SLAY
ReturnHeader/Filer/EIN0810699146
ReturnHeader/Filer/PhoneNum02159329040
ReturnHeader/Filer/USAddress/AddressLine1Txt0609 LAUREN CIRCLE
ReturnHeader/Filer/USAddress/CityNm0YARDLEY
ReturnHeader/Filer/USAddress/StateAbbreviationCd0PA
ReturnHeader/Filer/USAddress/ZIPCd019067
ReturnHeader/IRSResponsiblePrtyInfoCurrInd0false
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0934588212
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0FIVE POINTS FINANCIAL LLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt02667 NOTTINGHAM WAY
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0HAMILTON
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0NJ
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd008619
ReturnHeader/PreparerPersonGrp/PhoneNum06095863600
ReturnHeader/PreparerPersonGrp/PreparationDt02025-04-29
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0DAVID A LAUER CPA
ReturnHeader/ReturnTs02025-05-12T11:42:11-04:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02024-01-01
ReturnHeader/TaxPeriodEndDt02024-12-31
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.